Inclusion Criteria:~* National Institute on Aging/Alzheimer's Association core clinical criteria for probable
AD dementia~* Evidence of the AD pathological process, by a positive amyloid assessment either on CSF AÎ²1-42
as measured on Elecsys Î²-Amyloid(1-42) Test System OR amyloid PET scan~* AD dementia of moderate severity, as
defined by a screening MMSE score of 16-21 points, inclusive, and a CDR-GS of 1 or 2~* Availability of a person
with sufficient contact with the participant to be able to provide accurate information on the participant's
cognitive, behavioral and functional ability~
